Calamos Advisors LLC Invests $134,000 in CVRx, Inc. (NASDAQ:CVRX)

Calamos Advisors LLC acquired a new stake in CVRx, Inc. (NASDAQ:CVRX) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,596 shares of the company’s stock, valued at approximately $134,000.

Several other hedge funds have also added to or reduced their stakes in CVRX. Dimensional Fund Advisors LP acquired a new stake in shares of CVRx during the second quarter worth $218,000. Marshall Wace LLP acquired a new stake in CVRx in the 2nd quarter valued at approximately $495,000. SG Americas Securities LLC bought a new stake in CVRx in the 3rd quarter valued at approximately $108,000. International Assets Investment Management LLC acquired a new position in CVRx during the 3rd quarter worth approximately $338,000. Finally, PDT Partners LLC bought a new position in shares of CVRx during the 3rd quarter worth approximately $543,000. Institutional investors and hedge funds own 75.27% of the company’s stock.

Wall Street Analysts Forecast Growth

CVRX has been the topic of a number of analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $14.00 price objective on shares of CVRx in a research note on Wednesday, October 23rd. William Blair raised CVRx from a “market perform” rating to an “outperform” rating in a report on Tuesday, January 14th. Canaccord Genuity Group lifted their target price on CVRx from $22.00 to $23.00 and gave the stock a “buy” rating in a report on Wednesday. Craig Hallum upped their price target on shares of CVRx from $20.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, January 17th. Finally, Lake Street Capital raised their price target on shares of CVRx from $12.00 to $15.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, CVRx presently has a consensus rating of “Moderate Buy” and a consensus price target of $17.83.

CVRx Trading Down 2.5 %

CVRX opened at $14.71 on Friday. The company has a quick ratio of 10.23, a current ratio of 11.32 and a debt-to-equity ratio of 0.76. CVRx, Inc. has a twelve month low of $6.40 and a twelve month high of $25.03. The stock has a market capitalization of $356.86 million, a price-to-earnings ratio of -5.45 and a beta of 1.29. The company has a 50-day simple moving average of $14.70 and a 200 day simple moving average of $11.75.

CVRx (NASDAQ:CVRX) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.06). CVRx had a negative net margin of 123.75% and a negative return on equity of 89.06%. Analysts predict that CVRx, Inc. will post -2.61 EPS for the current fiscal year.

CVRx Profile

CVRx, Inc, a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure.